Samia B.

We are HawkCell, and we act now. Were on a mission to make the healthcare industry more efficient and sustainable. We do this one animal MRI image at a time with a patented plug-and-play solution turning human MRI into an animal-dedicated one for veterinary clinics and preclinical research labs. Were a young company, but were well on our way to becoming the undisputed leader in animal imaging. After consolidating our presence in Europe, we have the ambition to expand rapidly to the United States and Asia and become the undisputed leader of MRI for animals. Today, HawkCell is the only player offering augmented MRI solutions with strategic partnerships with the leading MRI manufacturers. In 2022, our playing field is a serviceable obtainable market (SOM) evaluated at 700 million USD… a market growing at double digits YoY. We believe theres a better way to do healthcare, better for everyone — animals and humans. Visit our website www.hawkcell.com and join us in our ambitious mission.

Building a sustainable future together. Microalgae are able to propose solutions to many challenges of the positive economy. We cultivate them for various applications and animal nutrition in particular.

Numalis provides tools and develops ISO standards to facilitate the adoption of AI throughout the industry. Its disruptive innovation helps design artificial intelligence algorithms to make them more robust and explainable. https://saimple.com Through its Saimple tools range, Numalis enables AI engineers to address two issues that slow down the adoption of AI: proving their robustness and their explainability. To address these issues, Numalis’ tools are the first to rely on formal methods capable of satisfying the stringent safety requirements of sectors such as transportation, defense, healthcare and even finance.

ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, plant development and climate data to quantify the results obtained under real-life conditions.

🍀 Créée par Thomas Perret, Mon Petit Placement est une fintech qui permet de rendre linvestissement plus simple et plus accessible à tous. Dès 300€, vous pouvez faire fructifier votre argent grâce à une assurance-vie ou un PER tout en bénéficiant dun accompagnement personnalisé (et humain) et dune interface simplifiée. En quelques chiffres, Mon Petit Placement cest : • 25 000 clients • 160M€ gérés • 3 partenaires assureurs de confiance (Apicil, Generali et La France Mutualiste) Investir comporte des risques en perte de capital.

Adionics is a privated company created in 2012 after five years of research with the ambition of becoming a leading technology provider in saline water valorization. Adionics has succeeded in developing a highly selective extractant composition (Flionex) for the extraction of lithium salts. The technology developed by Adionics is based on the implementation of a patented process of selective extraction of salts. It uses liquid-liquid extraction technologies (absorption / desorption process of ionic species from brine) to produce a purified lithium chloride concentrated brine. Our Direct Lithium Extraction (DLE) is a great lever to reduce the environmental footprint along energy, water, production time.

Yposkesi is one of the largest Contract Development & Manufacturing Organizations (CDMO) in Europe for gene therapy viral vector manufacturing. A spin-off from the world-class gene therapy pioneer Genethon, Yposkesi capitalizes on more than 20 years’ expertise in biotherapeutic research. Integrated Services It offer customers a full service: bioprocess development (upstream and downstream processing), small/pilot to large-scale production, analytical development, GMP manufacturing of clinical lots of lentiviral and AAV (Adeno-Associated Virus) vectors and regulatory support. Capacity Its current 50,000ft2 state-of-the-art facility designed for high efficiency houses four independent manufacturing suites for bulk drug substance and two fill & finish suites. It is doubling this footprint to 100,000ft2 to expand its capacity to support the clinical and future commercial needs of its clients. Innovation Yposkesi invests significantly in bioprocessing innovation aimed at improving the cost-effectiveness of gene therapy manufacturing. Founded in 2016 by patient association AFM-Telethon and the SPI investment fund from BpiFrance, the state-owned French investment bank, Yposkesi is driving its ambitions through the leadership of directors with an established track record in gene therapy and pharmaceutical GMP-biomanufacturing. The company is located in Corbeil-Essonnes, near Paris, and employs 160 industrial and technical specialists.

AFYREN industrialises innovative processes worldwide, with the aim of producing without waste, natural molecules usually petro-sourced, used to manufacture everyday products (food, cosmetics, agronomy), while respecting the environment. The non-food biomass transformed by the AFYNERIE ® process produces synthons (from 2 to 6 carbons) that will lead via green chemistry to a range of high value-added molecules.

Yposkesi is one of the largest Contract Development & Manufacturing Organizations (CDMO) in Europe for gene therapy viral vector manufacturing. A spin-off from the world-class gene therapy pioneer Genethon, Yposkesi capitalizes on more than 20 years’ expertise in biotherapeutic research. Integrated Services It offer customers a full service: bioprocess development (upstream and downstream processing), small/pilot to large-scale production, analytical development, GMP manufacturing of clinical lots of lentiviral and AAV (Adeno-Associated Virus) vectors and regulatory support. Capacity Its current 50,000ft2 state-of-the-art facility designed for high efficiency houses four independent manufacturing suites for bulk drug substance and two fill & finish suites. It is doubling this footprint to 100,000ft2 to expand its capacity to support the clinical and future commercial needs of its clients. Innovation Yposkesi invests significantly in bioprocessing innovation aimed at improving the cost-effectiveness of gene therapy manufacturing. Founded in 2016 by patient association AFM-Telethon and the SPI investment fund from BpiFrance, the state-owned French investment bank, Yposkesi is driving its ambitions through the leadership of directors with an established track record in gene therapy and pharmaceutical GMP-biomanufacturing. The company is located in Corbeil-Essonnes, near Paris, and employs 160 industrial and technical specialists.

Bpifrance, Banque publique dinvestissement, accompagne les entreprises, de lamorçage jusquà la cotation en bourse, du crédit aux fonds propres. Interlocuteur privilégié, Bpifrance propose dans chaque région des solutions de financement ou d’investissement adaptées à chaque étape de la vie des entreprises. Banque partenaire des entrepreneurs, Bpifrance les accompagne durablement pour soutenir leur croissance et leur compétitivité. Les équipes sont au cœur des régions, sur l’ensemble du territoire, à travers plus de 50 implantations régionales.

Bpifrance, Banque publique dinvestissement, accompagne les entreprises, de lamorçage jusquà la cotation en bourse, du crédit aux fonds propres. Interlocuteur privilégié, Bpifrance propose dans chaque région des solutions de financement ou d’investissement adaptées à chaque étape de la vie des entreprises. Banque partenaire des entrepreneurs, Bpifrance les accompagne durablement pour soutenir leur croissance et leur compétitivité. Les équipes sont au cœur des régions, sur l’ensemble du territoire, à travers plus de 50 implantations régionales.

Bpifrance, Banque publique dinvestissement, accompagne les entreprises, de lamorçage jusquà la cotation en bourse, du crédit aux fonds propres. Interlocuteur privilégié, Bpifrance propose dans chaque région des solutions de financement ou d’investissement adaptées à chaque étape de la vie des entreprises. Banque partenaire des entrepreneurs, Bpifrance les accompagne durablement pour soutenir leur croissance et leur compétitivité. Les équipes sont au cœur des régions, sur l’ensemble du territoire, à travers plus de 50 implantations régionales.

We are HawkCell, and we act now. Were on a mission to make the healthcare industry more efficient and sustainable. We do this one animal MRI image at a time with a patented plug-and-play solution turning human MRI into an animal-dedicated one for veterinary clinics and preclinical research labs. Were a young company, but were well on our way to becoming the undisputed leader in animal imaging. After consolidating our presence in Europe, we have the ambition to expand rapidly to the United States and Asia and become the undisputed leader of MRI for animals. Today, HawkCell is the only player offering augmented MRI solutions with strategic partnerships with the leading MRI manufacturers. In 2022, our playing field is a serviceable obtainable market (SOM) evaluated at 700 million USD… a market growing at double digits YoY. We believe theres a better way to do healthcare, better for everyone — animals and humans. Visit our website www.hawkcell.com and join us in our ambitious mission.

Building a sustainable future together. Microalgae are able to propose solutions to many challenges of the positive economy. We cultivate them for various applications and animal nutrition in particular.

Numalis provides tools and develops ISO standards to facilitate the adoption of AI throughout the industry. Its disruptive innovation helps design artificial intelligence algorithms to make them more robust and explainable. https://saimple.com Through its Saimple tools range, Numalis enables AI engineers to address two issues that slow down the adoption of AI: proving their robustness and their explainability. To address these issues, Numalis’ tools are the first to rely on formal methods capable of satisfying the stringent safety requirements of sectors such as transportation, defense, healthcare and even finance.

ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, plant development and climate data to quantify the results obtained under real-life conditions.

🍀 Créée par Thomas Perret, Mon Petit Placement est une fintech qui permet de rendre linvestissement plus simple et plus accessible à tous. Dès 300€, vous pouvez faire fructifier votre argent grâce à une assurance-vie ou un PER tout en bénéficiant dun accompagnement personnalisé (et humain) et dune interface simplifiée. En quelques chiffres, Mon Petit Placement cest : • 25 000 clients • 160M€ gérés • 3 partenaires assureurs de confiance (Apicil, Generali et La France Mutualiste) Investir comporte des risques en perte de capital.